| Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema (NCT00799227) | Allergan | 2009-01-01 |
| Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema (NCT02310295) | University of Sao Paulo | 2009-01-01 |
| DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact (NCT00789477) | Regeneron Pharmaceuticals | 2008-12-01 |
| Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema (NCT00768040) | Novartis Pharmaceuticals | 2008-09-01 |
| Effect of Choline Fenofibrate (SLV348) on Macular Edema (NCT00683176) | Abbott Products | 2008-09-01 |
| Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy (NCT01259609) | Seoul National University Hospital | 2008-09-01 |
| Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. (NCT00758628) | Bp Consulting, Inc | 2008-08-01 |
| Bevacizumab Versus Ranibizumab for Diabetic Retinopathy (NCT00545870) | Ursula Schmidt-Erfurth, M.D. | 2008-06-01 |
| Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema (NCT00656643) | Santen Inc. | 2008-06-01 |
| Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) (NCT00885794) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2008-05-01 |
| A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study (NCT00687804) | Novartis | 2008-05-01 |
| Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy (NCT00665106) | Santen SAS | 2008-04-01 |
| Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study (NCT00676559) | Johns Hopkins University | 2008-04-01 |
| Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema (NCT00874744) | Universidade Federal de Goias | 2008-03-01 |
| Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function (NCT00759044) | Association for Innovation and Biomedical Research on Light and Image | 2008-03-01 |
| Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion (NCT00815360) | Retina Associates of Florida, P.A. | 2008-02-01 |
| Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema (NCT00682539) | Medical University of Vienna | 2007-10-01 |
| Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) (NCT00536692) | CoMentis | 2007-09-01 |
| Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery (NCT00801450) | University of Sao Paulo | 2007-09-01 |
| Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema (NCT00344968) | Alimera Sciences | 2007-09-01 |
| Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema (NCT00490815) | Alimera Sciences | 2007-08-01 |
| Treatment of Refractory Diabetic Macular Edema With Infliximab (NCT00505947) | University of Athens | 2007-07-01 |
| Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser (NCT00491166) | Ophthalmic Consultants of Boston | 2007-06-01 |
| Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema (NCT00464685) | Allergan | 2007-05-01 |
| Unilateral Bevacizumab for Bilateral Diabetic Macular Edema (NCT00496405) | Asociación para Evitar la Ceguera en México | 2007-04-01 |
| Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema (NCT00563940) | Insel Gruppe AG, University Hospital Bern | 2007-03-01 |
| Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy (NCT00445003) | Jaeb Center for Health Research | 2007-03-01 |
| Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema (NCT00444600) | Jaeb Center for Health Research | 2007-03-01 |
| Micropulse 810 Nanomolar (nm), Diode Laser for Diffuse Diabetic Macular Edema (NCT00552435) | Federal University of São Paulo | 2007-03-01 |
| The Course of Response to Focal Photocoagulation for DME (NCT00442156) | Jaeb Center for Health Research | 2007-01-01 |
| The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study (NCT00407381) | Johns Hopkins University | 2006-12-01 |
| A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) (NCT00412451) | ThromboGenics | 2006-12-01 |
| Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) (NCT00446381) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-10-01 |
| Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy (NCT00401115) | Santen Inc. | 2006-09-01 |
| Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema (NCT00387582) | Rocky Mountain Retina Consultants | 2006-07-01 |
| Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema (NCT00320814) | Regeneron Pharmaceuticals | 2006-04-01 |
| Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study) (NCT00468351) | University of Sao Paulo | 2006-04-01 |
| Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema (NCT00994955) | University Hospital Schleswig-Holstein | 2006-01-01 |
| Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema (NCT00306904) | OPKO Health, Inc. | 2006-01-01 |
| Triamcinolone vs. Laser for Diabetic Macular Edema (NCT00229931) | University of Oklahoma | 2005-11-01 |
| Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema (NCT00370669) | Shahid Beheshti University of Medical Sciences | 2005-11-01 |
| Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial (NCT00370422) | Shahid Beheshti University of Medical Sciences | 2005-11-01 |
| Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement (NCT00284050) | Novartis | 2005-10-01 |
| Observational Study of DME Following Scatter Laser Photocoagulation (NCT00687154) | Jaeb Center for Health Research | 2005-09-01 |
| Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema (NCT00417716) | Asociación para Evitar la Ceguera en México | 2005-09-01 |
| Evaluation of Vitrectomy for Diabetic Macular Edema (NCT00709319) | Jaeb Center for Health Research | 2005-07-01 |
| Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema (NCT00915837) | SurModics, Inc. | 2005-06-01 |
| A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema (NCT00168337) | Allergan | 2005-05-01 |
| Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema (NCT00371410) | Samsung Medical Center | 2005-04-01 |
| Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation (NCT00105404) | National Eye Institute (NEI) | 2005-03-09 |
| A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema (NCT00168389) | Allergan | 2005-02-01 |
| Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema (NCT00764244) | Assistance Publique - Hôpitaux de Paris | 2005-01-01 |
| A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema (NCT00369486) | Jaeb Center for Health Research | 2004-12-01 |
| Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema (NCT00367133) | Jaeb Center for Health Research | 2004-07-01 |
| A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema (NCT00071773) | Jaeb Center for Health Research | 2003-07-01 |
| Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema (NCT00576459) | Bausch & Lomb Incorporated | 2003-03-01 |
| A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema (NCT00369863) | Shahid Beheshti University of Medical Sciences | 2002-06-01 |
| Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema (NCT00502541) | Bausch & Lomb Incorporated | 2001-09-01 |
| A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema (NCT01487044) | Retina Institute of Hawaii | |
| Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) (NCT01411254) | Santen Pharmaceutical Co., Ltd. | |
| A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema (NCT00308542) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema (NCT02645734) | Shahid Beheshti University of Medical Sciences | |